CD55 and Global developmental delay: Furthermore, the cell surface levels of CD55 and CD59 were on average lower in cells that were derived from individuals with mutations in PGAP3 compared to individuals with mutations in PIGV (Additional file 1: Table S1), although this did not correspond to a higher prevalence of seizures or a more severe developmental delay.